Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs ETHSX overlap: 63% of top holdings shared

Bottom line

How much do FHLC and ETHSX overlap?

63% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 56.6% of FHLC's assets and 60.3% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.

FHLC holds far more positions (337 vs 42), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCETHSX
Weight overlap (top 25)63%
Shared holdings14
Weight in shared holdings56.6%60.3%
Total positions33742
Expense ratio0.084%1.18%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings FHLC and ETHSX have in common

Holding% of FHLC% of ETHSXOverlap
Eli Lilly & Co13.35%12.47%12.47%
Johnson & Johnson8.93%6.45%6.45%
AbbVie Inc6.42%6.46%6.42%
UnitedHealth Group Inc5.44%5.49%5.44%
Merck & Co Inc4.66%5.08%4.66%
Thermo Fisher Scientific Inc3.09%2.79%2.79%
Abbott Laboratories2.66%1.65%1.65%
Gilead Sciences Inc2.34%3.34%2.34%
Bristol-Myers Squibb Co1.93%4.25%1.93%
Intuitive Surgical Inc1.82%2.72%1.82%
Vertex Pharmaceuticals Inc1.76%3.38%1.76%
Stryker Corp1.62%2.21%1.62%
Medtronic PLC1.59%1.80%1.59%
Boston Scientific Corp1.00%2.18%1.00%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Amgen Inc — 3.00%
  2. Pfizer Inc — 2.06%
  3. CVS Health Corp — 1.92%
  4. Danaher Corp — 1.80%
  5. McKesson Corp — 1.52%
  6. Elevance Health Inc — 1.19%
  7. Regeneron Pharmaceuticals Inc — 1.15%
  8. Cigna Group/The — 1.06%
  9. HCA Healthcare Inc — 0.91%
  10. Cencora Inc — 0.83%
  11. Cardinal Health Inc — 0.78%

Only in ETHSX

  1. AstraZeneca PLC — 6.24%
  2. Roche Holding AG — 5.44%
  3. Sanofi SA — 2.95%
  4. Lonza Group AG — 1.77%
  5. Novo Nordisk A/S — 1.71%
  6. Novartis AG — 1.65%
  7. Argenx SE — 1.61%
  8. Royalty Pharma PLC — 1.58%
  9. Neurocrine Biosciences Inc — 1.41%
  10. Mettler-Toledo International Inc — 1.36%
  11. Straumann Holding AG — 1.34%

Asset mix

Asset typeFHLCETHSX
Stocks99.7%99.4%
Cash & short-term funds0.2%0.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryFHLCETHSX
US96.5%69.4%
CH0.1%10.2%
GB0.5%7.8%
FR—3.2%
DK—2.9%
IE2.2%1.8%
NL0.1%2.0%
AU—0.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do FHLC and ETHSX overlap?
About 63% by weight. 14 securities appear in both funds' top 25 holdings; they make up 56.6% of FHLC's assets and 60.3% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FHLC and ETHSX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc, Merck & Co Inc.
Should I own both FHLC and ETHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FHLC or ETHSX?
FHLC is broader, with 337 positions versus 42 for ETHSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.